Published in In Vivo on April 25, 2006
Biomechanics of the sensor-tissue interface-effects of motion, pressure, and design on sensor performance and the foreign body response-part I: theoretical framework. J Diabetes Sci Technol (2011) 1.18
Clinical evaluation of a transcutaneous interrogated fluorescence lifetime-based microsensor for continuous glucose reading. J Diabetes Sci Technol (2009) 0.96
Recent advances in continuous glucose monitoring: biocompatibility of glucose sensors for implantation in subcutis. J Diabetes Sci Technol (2007) 0.81
Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing. Antimicrob Agents Chemother (2008) 2.13
Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not. Diabetes (2007) 1.64
Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol. J Invest Dermatol (2003) 1.30
Use of the Göttingen minipig as a model of diabetes, with special focus on type 1 diabetes research. ILAR J (2004) 1.29
GLP-1 derivative liraglutide in rats with beta-cell deficiencies: influence of metabolic state on beta-cell mass dynamics. Br J Pharmacol (2003) 1.23
Measurements of insulin responses as predictive markers of pancreatic beta-cell mass in normal and beta-cell-reduced lean and obese Göttingen minipigs in vivo. Am J Physiol Endocrinol Metab (2005) 1.07
Biocompatibility of electrochemical glucose sensors implanted in the subcutis of pigs. Diabetes Technol Ther (2006) 1.05
Mild streptozotocin diabetes in the Göttingen minipig. A novel model of moderate insulin deficiency and diabetes. Am J Physiol Endocrinol Metab (2002) 1.04
The impact of tail tip amputation and ink tattoo on C57BL/6JBomTac mice. Lab Anim (2007) 0.95
Juvenile kyphosis in pigs. A spontaneous model of Scheuermann's kyphosis. APMIS (2005) 0.94
Biocompatibility of an enzyme-based, electrochemical glucose sensor for short-term implantation in the subcutis. Diabetes Technol Ther (2006) 0.89
NN2211: a long-acting glucagon-like peptide-1 derivative with anti-diabetic effects in glucose-intolerant pigs. Eur J Pharmacol (2002) 0.89
Embolic encephalitis in a porcine model of endocarditis. In Vivo (2013) 0.88
High-fat high-energy feeding impairs fasting glucose and increases fasting insulin levels in the Göttingen minipig: results from a pilot study. Ann N Y Acad Sci (2002) 0.88
A porcine model of acute, haematogenous, localized osteomyelitis due to Staphylococcus aureus: a pathomorphological study. APMIS (2010) 0.87
Comparison of chromatographic ion-exchange resins. III. Strong cation-exchange resins. J Chromatogr A (2004) 0.85
Actinobacillus equuli subsp. equuli associated with equine valvular endocarditis. APMIS (2007) 0.84
Chamber-dependent expression of brain natriuretic peptide and its mRNA in normal and diabetic pig heart. Hypertension (2002) 0.83
Valine pyrrolidide preserves intact glucose-dependent insulinotropic peptide and improves abnormal glucose tolerance in minipigs with reduced beta-cell mass. Exp Diabesity Res (2003) 0.81
Serum amyloid A is expressed in histologically normal tissues from horses and cattle. Vet Immunol Immunopathol (2011) 0.79
Recombinant adiponectin does not lower plasma glucose in animal models of type 2 diabetes. PLoS One (2012) 0.79
Effect of subcutaneous glucose sensor implantation on skin mRNA expression in pigs. Diabetes Technol Ther (2010) 0.79
Functional characterization of a porcine emphysema model. Lung (2013) 0.77
Comparison of chromatographic ion-exchange resins IV. Strong and weak cation-exchange resins and heparin resins. J Chromatogr A (2005) 0.76
Successful treatment of an intra-pelvic fungal pseudomycetoma causing constipation and hypercalcaemia in a Persian cat. J Feline Med Surg (2013) 0.75
In vitro and in vivo characteristics of celecoxib in situ formed suspensions for intra-articular administration. J Pharm Sci (2011) 0.75